Leukemia & Lymphoma, Volume 56, Issue 10 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 56, Issue 10 (2015)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Volume 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Allo-transplant for older patients with acute lymphoblastic leukemia: does it work?
Partow Kebriaei
Pages: 2753-2754
Published online: 27 Mar 2015
CitationforAllo-transplant for older patients with acute lymphoblastic leukemia: does it work? | Full Text | References | PDF (173.7 KB) | Supplemental
  • 88 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
The rosy future of BCL-2 inhibition in chronic lymphocytic leukemia: pursuit of a worthy target
Jennifer R. Brown
Pages: 2755-2756
Published online: 18 Jun 2015
CitationforThe rosy future of BCL-2 inhibition in chronic lymphocytic leukemia: pursuit of a worthy target | Full Text | References | PDF (180.8 KB) | Supplemental
  • 95 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Utility of the immunoglobulin free light chain assay for plasma cell disorders 2015
Morie A. Gertz
Pages: 2757-2758
Published online: 27 Mar 2015
CitationforUtility of the immunoglobulin free light chain assay for plasma cell disorders 2015 | Full Text | References | PDF (179.2 KB) | Supplemental
  • 147 Views
  • 2 CrossRef citations
  • 0Altmetric

Reviews

Clinicopathologic features and management of blastoid variant of mantle cell lymphoma
Rajesh Shrestha, Vijaya Raj Bhatt, Guru Subramanian Guru Murthy & James O. Armitage
Pages: 2759-2767
Published online: 27 Mar 2015
AbstractforClinicopathologic features and management of blastoid variant of mantle cell lymphoma | Full Text | References | PDF (327.3 KB) | Supplemental
  • 990 Views
  • 18 CrossRef citations
  • 0Altmetric
Novel therapies for myelofibrosis
Brady L. Stein, Francisco Cervantes, Francis Giles, Claire N. Harrison & Srdan Verstovsek
Pages: 2768-2778
Published online: 18 May 2015
AbstractforNovel therapies for myelofibrosis | Full Text | References | PDF (326.8 KB) | Supplemental
  • 663 Views
  • 5 CrossRef citations
  • 0Altmetric
Management of adverse events associated with idelalisib treatment: expert panel opinion
Steven E. Coutré, Jacqueline C. Barrientos, Jennifer R. Brown, Sven de Vos, Richard R. Furman, Michael J. Keating, Daniel Li, Susan M. O’Brien, John M. Pagel, Martin H. Poleski, Jeff P. Sharman, Nai-Shun Yao & Andrew D. Zelenetz
Pages: 2779-2786
Published online: 19 May 2015
AbstractforManagement of adverse events associated with idelalisib treatment: expert panel opinion | Full Text | References | PDF (445.7 KB) | Supplemental
  • 12116 Views
  • 239 CrossRef citations
  • 0Altmetric
Open Access

Original Articles: Clinical

Survival disparities by age and country of diagnosis for patients with acute leukemia
Maria Theresa Redaniel, Dianne Pulte & Mona Jeffreys
Pages: 2787-2792
Published online: 06 Mar 2015
AbstractforSurvival disparities by age and country of diagnosis for patients with acute leukemia | Full Text | References | PDF (213.3 KB) | Supplemental
  • 228 Views
  • 7 CrossRef citations
  • 0Altmetric
A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia
Jonathan How, Mark D. Minden, Leber Brian, Eric X. Chen, Joseph Brandwein, Andre C. Schuh, Aaron D. Schimmer, Vikas Gupta, Sheila Webster, Tammy Degelder, Patricia Haines, Lee-Anne Stayner, Shauna McGill, Lisa Wang, Richard Piekarz, Tracy Wong, Lillian L. Siu, Igor Espinoza-Delgado, Julianne L. Holleran, Merrill J. Egorin & Karen W. L. Yee
Pages: 2793-2802
Published online: 30 Mar 2015
AbstractforA phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia | Full Text | References | PDF (301.5 KB) | Supplemental
  • 415 Views
  • 22 CrossRef citations
  • 0Altmetric
Medical complications, resource utilization and costs in patients with myelofibrosis by frequency of blood transfusion and iron chelation therapy
Francis Vekeman, Wendy Y. Cheng, Medha Sasane, Lynn Huynh, Mei Sheng Duh, Carole Paley & Ruben A. Mesa
Pages: 2803-2811
Published online: 30 Mar 2015
AbstractforMedical complications, resource utilization and costs in patients with myelofibrosis by frequency of blood transfusion and iron chelation therapy | Full Text | References | PDF (280.2 KB) | Supplemental
  • 403 Views
  • 1 CrossRef citations
  • 0Altmetric
Impact of transplant eligibility and availability of a human leukocyte antigen-identical matched related donor on outcome of older patients with acute lymphoblastic leukemia
Pere Barba, Rodrigo Martino, David Martinez-Cuadron, García Olga, Albert Esquirol, Cristina Gil-Cortés, José Gonzalez, Francesc Fernandez-Avilés, David Valcárcel, Ramón Guardia, Rafael F. Duarte, Jesús Maria Hernandez-Rivas, Eugenia Abella, Pau Montesinos & Josep Maria Ribera
Pages: 2812-2818
Published online: 06 Mar 2015
AbstractforImpact of transplant eligibility and availability of a human leukocyte antigen-identical matched related donor on outcome of older patients with acute lymphoblastic leukemia | Full Text | References | PDF (259.3 KB) | Supplemental
  • 177 Views
  • 4 CrossRef citations
  • 0Altmetric
An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia
William Nigel Patton, Robert Lindeman, Andrew C. Butler, Thomas J. Kipps, Roxanne C. Jewell, Kevin H. Laubscher, Yan Yan Zhou, Eric Lewis, Donna Sedoti, Philip Witman, Lei Fang & Geoffrey Chan
Pages: 2819-2825
Published online: 26 Feb 2015
AbstractforAn open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia | Full Text | References | PDF (286.5 KB) | Supplemental
  • 136 Views
  • 4 CrossRef citations
  • 0Altmetric
A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia
Thomas J. Kipps, Herbert Eradat, Sebastian Grosicki, John Catalano, Walter Cosolo, Iryna S. Dyagil, Sreeni Yalamanchili, Akiko Chai, Srikumar Sahasranaman, Elizabeth Punnoose, Deborah Hurst & Halyna Pylypenko
Pages: 2826-2833
Published online: 12 May 2015
AbstractforA phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia | Full Text | References | PDF (334.1 KB) | Supplemental
  • 891 Views
  • 132 CrossRef citations
  • 0Altmetric
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma
Farrukh T. Awan, Joseph M. Flynn, Jeffrey A. Jones, Leslie A. Andritsos, Kami J. Maddocks, Ellen J. Sass, Margaret S. Lucas, Weihong Chase, Sharon Waymer, Yonghua Ling, Yao Jiang, Mitch A. Phelps, John C. Byrd, David M. Lucas & Jennifer A. Woyach
Pages: 2834-2840
Published online: 11 Mar 2015
AbstractforPhase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma | Full Text | References | PDF (317 KB) | Supplemental
  • 303 Views
  • 12 CrossRef citations
  • 0Altmetric
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience
Luca Laurenti, Francesco Autore, Idanna Innocenti, Barbara Vannata, Nicola Piccirillo, Federica Sorà, Domenico Speziale, Maurizio Pompili, Dimitar Efremov & Simona Sica
Pages: 2841-2846
Published online: 14 Mar 2015
AbstractforPrevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience | Full Text | References | PDF (355.7 KB) | Supplemental
  • 290 Views
  • 9 CrossRef citations
  • 0Altmetric
Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma
Ellen J. Kim, Youn H. Kim, Alain H. Rook, Adam Lerner, Madeleine Duvic, Sunil Reddy, Tadeusz Robak, Jürgen C. Becker, Alexey Samtsov, William McCulloch, Joel Waksman & Sean Whittaker
Pages: 2847-2854
Published online: 20 May 2015
AbstractforClinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma | Full Text | References | PDF (238.8 KB) | Supplemental
  • 1578 Views
  • 17 CrossRef citations
  • 0Altmetric
Open Access
Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphoma
Megan V. Caram, Emily L. Bellile, Michael J. Englesbe, Michael Terjimanian, Stewart C. Wang, Jennifer J. Griggs & Daniel Couriel
Pages: 2855-2862
Published online: 18 Jun 2015
AbstractforSarcopenia is associated with autologous transplant-related outcomes in patients with lymphoma | Full Text | References | PDF (281.1 KB) | Supplemental
  • 490 Views
  • 27 CrossRef citations
  • 0Altmetric
A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma
Nina D. Wagner-Johnston, Andrè Goy, Maria A. Rodriguez, W. Christopher Ehmann, Paul A. Hamlin, John Radford, Catherine Thieblemont, Cheolwon Suh, John Sweetenham, Yifan Huang, Sharon T. Sullivan, Erik R. Vandendries & Christian Gisselbrecht
Pages: 2863-2869
Published online: 29 Mar 2015
AbstractforA phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma | Full Text | References | PDF (266.9 KB) | Supplemental
  • 787 Views
  • 28 CrossRef citations
  • 0Altmetric
Long-term follow up of rates of secondary malignancy and late relapse of two trials using radioimmunotherapy consolidation following induction chemotherapy for previously untreated indolent lymphoma
Jonathan Reiss, Brian Link, Jia Ruan, Richard Furman, Morton Coleman, John Leonard & Peter Martin
Pages: 2870-2875
Published online: 11 Mar 2015
AbstractforLong-term follow up of rates of secondary malignancy and late relapse of two trials using radioimmunotherapy consolidation following induction chemotherapy for previously untreated indolent lymphoma | Full Text | References | PDF (230.2 KB) | Supplemental
  • 325 Views
  • 13 CrossRef citations
  • 0Altmetric
Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma
Cédric Rossi, Jérémie Jégu, Morgane Mounier, Mylène Dandoit, Marc Colonna, Laetitia Daubisse-Marliac, Brigitte Trétarre, Olivier Ganry, Anne-Valérie Guizard, Simona Bara, Véronique Bouvier, Anne-Sophie Woronoff, Alain Monnereau, Olivier Casasnovas, Michel Velten, Xavier Troussard & Marc Maynadié
Pages: 2876-2882
Published online: 08 Mar 2015
AbstractforRisk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma | Full Text | References | PDF (237.1 KB) | Supplemental
  • 283 Views
  • 12 CrossRef citations
  • 0Altmetric
Dealing with bone marrow biopsies in the staging of classical Hodgkin lymphoma: an old issue revisited in the 18F-fluorodeoxyglucose-positron emission tomography era
Marianne de Castro Gonçalves, Henrique Moura de Paula, Camila da Cruz Gouveia Linardi, Juliano J Cerci, Vera Lucia Aldred, Sheila Aparecida Coelho Siqueira, Valeria Buccheri & Maria Claudia Nogueira Zerbini
Pages: 2883-2888
Published online: 24 Mar 2015
AbstractforDealing with bone marrow biopsies in the staging of classical Hodgkin lymphoma: an old issue revisited in the 18F-fluorodeoxyglucose-positron emission tomography era | Full Text | References | PDF (475.8 KB) | Supplemental
  • 171 Views
  • 2 CrossRef citations
  • 0Altmetric
Hematological toxicities associated with amphotericin B formulations
Diego R. Falci, Franciane B. da Rosa & Alessandro C. Pasqualotto
Pages: 2889-2894
Published online: 09 Feb 2015
AbstractforHematological toxicities associated with amphotericin B formulations | Full Text | References | PDF (209.7 KB) | Supplemental
  • 707 Views
  • 18 CrossRef citations
  • 0Altmetric
Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation
Zheng Zhou, Juehua Gao, Relja Popovic, Kristy Wolniak, Vamsi Parimi, Jane N. Winter, Jonathan D. Licht & Yi-Hua Chen
Pages: 2895-2901
Published online: 08 Mar 2015
AbstractforStrong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation | Full Text | References | PDF (608 KB) | Supplemental
  • 863 Views
  • 23 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course
Gulsum Emel Pamuk, Hilmi Tozkir, Mehmet Sevki Uyanik, Hakan Gurkan, Julide Duymaz & Omer Nuri Pamuk
Pages: 2902-2907
Published online: 27 Mar 2015
AbstractforNatural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course | Full Text | References | PDF (214.3 KB) | Supplemental
  • 214 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia
Maciej Grzywnowicz, Lidia Karabon, Agnieszka Karczmarczyk, Malgorzata Zajac, Katarzyna Skorka, Joanna Zaleska, Paulina Wlasiuk, Sylwia Chocholska, Waldemar Tomczak, Agnieszka Bojarska-Junak, Anna Dmoszynska, Irena Frydecka & Krzysztof Giannopoulos
Pages: 2908-2913
Published online: 14 Mar 2015
AbstractforThe function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia | Full Text | References | PDF (273.3 KB) | Supplemental
  • 593 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
DNMT3A R882 mutation is associated with elevated expression of MAFB and M4/M5 immunophenotype of acute myeloid leukemia blasts
Li Yang, Ya'Nan Liu, Li Zhu & Min Xiao
Pages: 2914-2922
Published online: 06 Jul 2015
AbstractforDNMT3A R882 mutation is associated with elevated expression of MAFB and M4/M5 immunophenotype of acute myeloid leukemia blasts | Full Text | References | PDF (1.2 MB) | Supplemental
  • 465 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Matrine suppresses cell growth of human chronic myeloid leukemia cells via its inhibition of the interleukin-6/Janus activated kinase/signal transducer and activator of transcription 3 signaling cohort
Lingdi Ma, Zhichao Zhu, Lijia Jiang, Xiao Sun, Xuzhang Lu, Min Zhou, Sixuan Qian & Li Jianyong
Pages: 2923-2930
Published online: 11 Mar 2015
AbstractforMatrine suppresses cell growth of human chronic myeloid leukemia cells via its inhibition of the interleukin-6/Janus activated kinase/signal transducer and activator of transcription 3 signaling cohort | Full Text | References | PDF (556 KB) | Supplemental
  • 200 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia
Yan-Fang Tao, Zhi-Heng Li, Na-Na Wang, Fang Fang, Li-Xiao Xu & Jian Pan
Pages: 2931-2944
Published online: 24 Feb 2015
Abstractfortp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia | Full Text | References | PDF (987.2 KB) | Supplemental
  • 185 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma
Danielle Bongero, Luca Paoluzzi, Enrica Marchi, Kelly M. Zullo, Roberto Neisa, Yinghui Mao, Rafael Escandon, Ken Wood & Owen A. O’Connor
Pages: 2945-2952
Published online: 14 May 2015
AbstractforThe novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphoma | Full Text | References | PDF (485.2 KB) | Supplemental
  • 320 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Gambogic acid induces death of K562 cells through autophagy and apoptosis mechanisms
Jinhao Chen, Min Zhou, Qian Zhang, Jingyan Xu & Jian Ouyang
Pages: 2953-2958
Published online: 20 May 2015
AbstractforGambogic acid induces death of K562 cells through autophagy and apoptosis mechanisms | Full Text | References | PDF (506.4 KB) | Supplemental
  • 205 Views
  • 8 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Serum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma
Ravi Vij, Michael Wang, Sundar Jagannath, Ruben Niesvizky, Andrzej J. Jakubowiak, Edward Kavalerchik, Mei Huang & David S. Siegel
Pages: 2959-2961
Published online: 12 May 2015
First Page PreviewforSerum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma | Full Text | References | PDF (186.8 KB) | Supplemental
  • 408 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Role of topotecan, vinorelbine, thiotepa and gemcitabine chemotherapy in relapsed/refractory adult acute leukemia
Samer A. Srour, Emily B. Borders, Mohamad A. Cherry, Jennifer Holter, Terence Herman & George B. Selby
Pages: 2962-2964
Published online: 31 Mar 2015
First Page PreviewforRole of topotecan, vinorelbine, thiotepa and gemcitabine chemotherapy in relapsed/refractory adult acute leukemia | Full Text | References | PDF (182.8 KB)
  • 218 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Co-infusion of mesenchymal stromal cells has no effect on relapse and infection in patients with leukemia undergoing haploidentical hematopoietic stem cell transplant
Dong-mei Han, Zhi-dong Wang, Xiao-li Zheng, Li Ding, Hong-min Yan, Mei Xue, Ling Zhu, Jing Liu & Heng-xiang Wang
Pages: 2965-2968
Published online: 24 Jun 2015
First Page PreviewforCo-infusion of mesenchymal stromal cells has no effect on relapse and infection in patients with leukemia undergoing haploidentical hematopoietic stem cell transplant | Full Text | References | PDF (267.2 KB) | Supplemental
  • 138 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
High resolution single nucleotide polymorphism array reveals cryptic indicating information about myelodysplastic syndrome-related myeloid malignancies
Kun Chi, Yang Li, Qiulan Ding, Lan Xu, Yu Chen & Xuefeng Wang
Pages: 2969-2972
Published online: 19 Jun 2015
First Page PreviewforHigh resolution single nucleotide polymorphism array reveals cryptic indicating information about myelodysplastic syndrome-related myeloid malignancies | Full Text | References | PDF (235.9 KB) | Supplemental
  • 124 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis
Lurdes Zamora, Blanca Xicoy, Marta Cabezón, Cristalina Fernandez, Silvia Marcé, Patricia Velez, Marisol Xandri, David Gallardo, Fuensanta Millá, Evarist Feliu & Concepción Boqué
Pages: 2973-2974
Published online: 11 Mar 2015
CitationforCo-existence of JAK2 V617F and CALR mutations in primary myelofibrosis | Full Text | References | PDF (242.3 KB) | Supplemental
  • 386 Views
  • 18 CrossRef citations
  • 0Altmetric
Letter
Immunohistochemical prognostication in diffuse large B-cell lymphoma: a single center 6-year retrospective analysis
Stephen D. Robinson, Joseph Gabriel, Andrew Webb, Timothy Corbett, Rosalynd Johnston, David Wright & Timothy J. Chevassut
Pages: 2975-2977
Published online: 06 Mar 2015
First Page PreviewforImmunohistochemical prognostication in diffuse large B-cell lymphoma: a single center 6-year retrospective analysis | Full Text | References | PDF (222.9 KB) | Supplemental
  • 114 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
B-cell precursor acute lymphoblastic leukemia with isolated t(14;19)(q32;q13) abnormality involving the CEBPG gene
Nina Haghi, Judith Brody, Nayyara Mahmood, Dipti Gheewala, Steven L. Allen, Chandrika Sreekantaiah & Xinmin Zhang
Pages: 2978-2981
Published online: 02 Mar 2015
First Page PreviewforB-cell precursor acute lymphoblastic leukemia with isolated t(14;19)(q32;q13) abnormality involving the CEBPG gene | Full Text | References | PDF (248.5 KB) | Supplemental
  • 217 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Serum soluble LR11, a novel tumor derived biomarker associated with the outcome of patients with diffuse large B-cell lymphoma
Chikako Ohwada, Atsuko Yamazaki, Takeharu Kawaguchi, Yasumasa Sugita, Masahiro Takeuchi, Naomi Shimizu, Emiko Sakaida, Yusuke Takeda, Shokichi Tsukamoto, Tomoya Muto, Meizi Jiang, Morihiro Higashi, Koutaro Yokote, Jun-ichi Tamaru, Hideaki Bujo & Chiaki Nakaseko
Pages: 2982-2985
Published online: 11 Mar 2015
First Page PreviewforSerum soluble LR11, a novel tumor derived biomarker associated with the outcome of patients with diffuse large B-cell lymphoma | Full Text | References | PDF (293.7 KB) | Supplemental
  • 156 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Dramatic efficacy of low dose lenalidomide as single agent in a patient with refractory gastric non-human immunodeficiency virus-associated plasmablastic lymphoma
Sylvain Carras, Caroline Regny, Michel Peoc'h, Julie Gervasoni, Remy Gressin, Jean-Yves Cahn & Lysiane Molina
Pages: 2986-2988
Published online: 10 Mar 2015
First Page PreviewforDramatic efficacy of low dose lenalidomide as single agent in a patient with refractory gastric non-human immunodeficiency virus-associated plasmablastic lymphoma | Full Text | References | PDF (212 KB) | Supplemental
  • 453 Views
  • 16 CrossRef citations
  • 0Altmetric
Letter
A unique presentation of unilateral pleural effusion in a patient with a high-grade plasma cell neoplasm
Al-Ola Abdallah, Meghana Bansal, Susan A. Kemp, Steven A. Schichman & Zhifu Xiang
Pages: 2989-2991
Published online: 12 May 2015
First Page PreviewforA unique presentation of unilateral pleural effusion in a patient with a high-grade plasma cell neoplasm | Full Text | References | PDF (282 KB) | Supplemental
  • 127 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
A translocation t(2;14)(p11.2;q32) involving rearrangements of immunoglobulin heavy chain and kappa light chain genes in B-cell lymphoma
Shivakumar Subramaniyam, Julia T. Geyer, Yen-Chun Liu & Susan Mathew
Pages: 2992-2994
Published online: 12 May 2015
First Page PreviewforA translocation t(2;14)(p11.2;q32) involving rearrangements of immunoglobulin heavy chain and kappa light chain genes in B-cell lymphoma | Full Text | References | PDF (243 KB) | Supplemental
  • 235 Views
  • 2 CrossRef citations
  • 0Altmetric

Correspondence

Rapid Communication
Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: tyrosine kinase inhibitors, donor lymphocyte infusions or both?
Ahmet Emre Eskazan, Isil Erdogan, Selin Berk, Fevzi Firat Yalniz, Tugrul Elverdi, Ayse Salihoglu & Teoman Soysal
Pages: 2995-2996
Published online: 28 Mar 2015
CitationforRelapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: tyrosine kinase inhibitors, donor lymphocyte infusions or both? | Full Text | References | PDF (237.4 KB) | Supplemental
  • 123 Views
  • 4 CrossRef citations
  • 0Altmetric
Rapid Communication
Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma
Emanuele Cencini, Alberto Fabbri, Luana Schiattone, Giulia Bartalucci & Monica Bocchia
Pages: 2997-2998
Published online: 23 Mar 2015
CitationforRadiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma | Full Text | References | PDF (196.9 KB) | Supplemental
  • 189 Views
  • 4 CrossRef citations
  • 0Altmetric
Rapid Communication
Radiotherapy in early stage follicular lymphoma: is it really the gold standard?
Andrea Janikova
Pages: 2999-3000
Published online: 18 Jun 2015
CitationforRadiotherapy in early stage follicular lymphoma: is it really the gold standard? | Full Text | References | PDF (181.6 KB) | Supplemental
  • 144 Views
  • 0 CrossRef citations
  • 0Altmetric
Rapid Communication
Optimizing the management of relapsed chronic myeloid leukemia post-allogeneic bone marrow transplant
Joshua F. Zeidner & B. Douglas Smith
Pages: 3001-3002
Published online: 19 Jun 2015
CitationforOptimizing the management of relapsed chronic myeloid leukemia post-allogeneic bone marrow transplant | Full Text | References | PDF (176.4 KB) | Supplemental
  • 86 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera
Ivan Krecak et al.
Letter to the Editor | Published online: 20 Jun 2024
Experience of using venetoclax in relapsed T- cell lymphoma
Jasmine Zain et al.
Letter to the Editor | Published online: 17 Jun 2024
Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Taylor Zak et al.
Article | Published online: 17 Jun 2024
Polycythemia vera: past, present and future
Ami B. Patel et al.
Review Article | Published online: 13 Jun 2024
View all latest articles